Nitazoxanide broad-spectrum antimicrobial: Began Phase II dose-ranging trial in 28 patients, which is funded by the licensor, Romark Laboratories (Tampa, Fla.)

Unimed Pharmaceuticals Inc. (UMED), Buffalo Grove, Ill. Product: Nitazoxanide broad-spectrum antimicrobial Indication: Cryptosporidium infection in AIDS Status: Began Phase II dose-ranging trial in 28...